These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 7651282

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Primary hyperaldosteronism and adenoma of the adrenal cortex. Suppression of aldosterone with dexamethasone].
    Bercovici JP, Roudaut N, Kerlan V, Aupetit-Faisant B, Floch HH.
    Ann Endocrinol (Paris); 1998 Apr; 59(1):20-2. PubMed ID: 9752394
    [Abstract] [Full Text] [Related]

  • 26. Hormonal characteristics of primary aldosteronism due to unilateral adrenal hyperplasia.
    Otsuka F, Otsuka-Misunaga F, Koyama S, Yamanari H, Ogura T, Ohe T, Makino H.
    J Endocrinol Invest; 1998 Sep; 21(8):531-6. PubMed ID: 9801995
    [Abstract] [Full Text] [Related]

  • 27. Detecting and treating primary aldosteronism: primary aldosteronism.
    Mantero F, Mattarello MJ, Albiger NM.
    Exp Clin Endocrinol Diabetes; 2007 Mar; 115(3):171-4. PubMed ID: 17427105
    [Abstract] [Full Text] [Related]

  • 28. Hyperaldosteronism: the internist's hypertensive disease.
    Brown CA, Bouldin MJ, Blackston JW, Duddleston DN, Shepherd JM, Hicks GS.
    Am J Med Sci; 2002 Oct; 324(4):227-31. PubMed ID: 12385496
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Genetic analysis of aldosterone synthase in patients with idiopathic hyperaldosteronism.
    Takeda Y, Furukawa K, Inaba S, Miyamori I, Mabuchi H.
    J Clin Endocrinol Metab; 1999 May; 84(5):1633-7. PubMed ID: 10323392
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Activity of [des-aspartyl1]-angiotensin II in primary aldosteronism.
    Carey RM, Ayers CR, Vaughan ED, Peach MJ, Herf SM.
    J Clin Invest; 1979 Apr; 63(4):718-26. PubMed ID: 438332
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Elevation of angiotensin-II type-1-receptor autoantibodies titer in primary aldosteronism as a result of aldosterone-producing adenoma.
    Rossitto G, Regolisti G, Rossi E, Negro A, Nicoli D, Casali B, Toniato A, Caroccia B, Seccia TM, Walther T, Rossi GP.
    Hypertension; 2013 Feb; 61(2):526-33. PubMed ID: 23248149
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Diagnosis and treatment of primary hyperaldosteronism.
    Blumenfeld JD, Sealey JE, Schlussel Y, Vaughan ED, Sos TA, Atlas SA, Müller FB, Acevedo R, Ulick S, Laragh JH.
    Ann Intern Med; 1994 Dec 01; 121(11):877-85. PubMed ID: 7978702
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Influence of angiotensin on the secretion of aldosterone in idiopathic hyperaldosteronism].
    Salvador M, Chamontin B, Rostaing L, Salva P.
    Arch Mal Coeur Vaiss; 1987 Jun 01; 80(6):992-4. PubMed ID: 3117000
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.